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Human herpesvirus entry mediator C (HveC) is an alphaherpesvirus receptor which binds to virion glycoprotein D (gD). We
identified porcine HveC and studied its interaction with pseudorabies virus (PrV) and herpes simplex virus type 1 (HSV-1) gD.
Porcine and human HveC have 96% amino acid identity and HveC from African green monkey, mouse, hamster, and cow are
similarly conserved. Porcine HveC mediates entry of HSV-1, HSV-2, PrV, and bovine herpesvirus type 1. Truncated soluble
forms of HSV-1 and PrV gD bind competitively to porcine HveC. Biosensor analysis shows that PrV gD binds with a 10-fold
higher affinity than HSV-1 gD. Monoclonal antibodies against human HveC recognize the porcine homologue and can block
gD binding and entry of HSV-1 and PrV. Porcine HveC is functionally indistinguishable from human HveC. Our results are
consistent with the suggestion that HveC is a pan-alphaherpesvirus receptor that interacts with a conserved structural
domain of gD. © 2001 Academic Press
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MINTRODUCTION
An early step in the entry of most alphaherpesviruses
into cells is the interaction of the virion envelope glyco-
protein D (gD) with one of numerous cell surface recep-
tors (Spear et al., 2000). To date, five human alphaher-
pesvirus receptors have been identified: herpes virus
entry mediator A (HveA, also known as HVEM and
TNFRSF14), a TNF receptor-related protein (Montgomery
et al., 1996); three immunoglobulin superfamily members:
HveB (PRR2, nectin 2), HveC (PRR1, nectin 1) and HveD
(PVR, CD155); and 3-O-sulfated heparan sulfate (Cocchi
et al., 1998b; Geraghty et al., 1998; Shukla et al., 1999a;
Warner et al., 1998). Although by definition each of these
eceptors mediates entry of at least one alphaherpesvi-
us, only one, HveC, can serve as a receptor for all of the
ommonly tested viruses: herpes simplex virus type 1
HSV-1), HSV-1 rid mutants, HSV-2, pseudorabies virus
PrV), and bovine herpesvirus type 1 (BHV-1; Cocchi et
l., 1998b; Geraghty et al., 1998).
The 346-amino acid extracellular domain of HveC
omprises 3 immunoglobulin (Ig)-like domains (Lopez et
l., 1995). The most N-terminal resembles a variable (V)
omain and the other two resemble constant (C) do-
ains. This overall structure is shared with HveB and
1 To whom reprint requests should be addressed at Department of
icrobiology, University of Pennsylvania, School of Dental Medicine,15 Levy Building, 4010 Locust Street, Philadelphia, PA 19104-6002. Fax:
215) 898 8385. E-mail: rmilne@biochem.dental.upenn.edu.
315ith the most recently described member of this group of
roteins, nectin 3 (Satoh-Horikawa et al., 2000; R.S.B.
ilne et al., unpublished). The natural function of HveC is
in cell adhesion. The C-terminus of HveC interacts with
an intracellular actin-binding protein, afadin, which in
turn localizes to cadherin adhesion junctions (Takahashi
et al., 1999). HveC is thought to participate in adhesion
via a homophilic trans interaction in which HveC on the
surface of one cell binds HveC on the surface of an
adjacent cell (Takahashi et al., 1999).
The entry mechanism of HSV and other alphaherpes-
viruses remains poorly understood. The initial contact
between HSV and a host cell is thought to be the inter-
action of viral glycoproteins C and B with cell surface
proteoglycans (Herold et al., 1994; WuDunn and Spear,
1989). Subsequently, the fusion of viral envelope and cell
membrane is brought about by the concerted actions of
at least four viral glycoproteins: gB, gD, gH, and gL
(Spear, 1993). Of the HSV-1 glycoproteins, only these four
are indispensable for normal virus entry in vitro (Cai et
al., 1988; Forrester et al., 1992; Ligas and Johnson, 1988;
Roop et al., 1993) and expression of the four proteins can
cause cell fusion (Klupp et al., 2000; Muggeridge, 2000;
Turner et al., 1998). To date, only gD has a clearly de-
monstrable function: receptor binding (Johnson and Li-
gas, 1988; Krummenacher et al., 1998; Whitbeck et al.,
1997).
gD is present in all of the commonly studied alphaher-
pesviruses, except for varicella-zoster virus, and is the
viral ligand for all of the recently identified alphaherpes-
0042-6822/01 $35.00
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316 MILNE ET AL.virus receptors. The gD homologues are considerably
diverged with, in the case of HSV-1 and PrV, only about
30% amino acid identity. However, the 6 cysteine resi-
dues in the extracellular domain are conserved, implying
that a common structure is retained. The remarkable
ability of all the gD homologues that have been tested to
bind HveC underlines the fact that the alphaherpesvi-
ruses have a common entry mechanism and highlights
the central role of the gD–HveC interaction in this.
Given that human HveC can mediate entry of the
animal alphaherpesviruses PrV and BHV-1 (Cocchi et al.,
1998b; Geraghty et al., 1998), it follows that HveC homo-
logues in other mammalian species may serve as recep-
tors for native alphaherpesviruses (Cocchi et al., 1998b;
Warner et al., 1998). The murine homologue of HveC has
been cloned and shown to be a functional alphaherpes-
virus receptor (Menotti et al., 2000; Shukla et al., 2000).
However, despite the use of PrV and BHV-1 in the char-
acterization of alphaherpesvirus receptors, information
about receptors from their natural host species is lack-
ing. We set out to test the hypothesis that alphaherpes-
viruses use HveC from their native hosts by studying the
interaction of PrV with porcine HveC.
PrV is the most intensively studied animal alphaher-
pesvirus and its gD homologue has been well charac-
terized (Rauh and Mettenleiter, 1991). There are signifi-
cant functional differences between HSV-1 and PrV gD.
PrV cannot use HveA for entry, but can use HveB and
HveD, whereas for wild-type HSV-1 the reverse is true
(Cocchi et al., 1998b; Geraghty et al., 1998; Montgomery
t al., 1996; Warner et al., 1998). We recently showed that
truncated soluble form of PrV gD binds human HveC
ith high affinity (Connolly et al., 2001). We were there-
fore interested to test whether PrV gD binds similarly to
porcine HveC or whether the established structural and
functional differences between PrV and HSV-1gD were
reflected in different interactions with the HveC homo-
logues from their natural host species.
In this article we show that the HveC homologues from
various mammalian species are remarkably conserved,
that PrV and HSV-1 gDt bind to porcine HveC competi-
tively but with different affinities, and that, with regard to
herpesvirus entry, porcine HveC is functionally indistin-
guishable from its human homologue.
RESULTS
HveC is highly conserved among mammalian species
Human HveC mediates entry of HSV-1, HSV-2, PrV, and
BHV-1 (Cocchi et al., 1998b; Geraghty et al., 1998); how-
ever, of these, only HSV-1 and -2 naturally infect humans.
The ability of viruses from other species to use human
HveC implies that animal homologues of this receptor
might play a role in the entry of native alphaherpesvi-
ruses. It has not been clear whether studies of the
interactions of animal viruses, such as PrV, with humanreceptors adequately model their interactions with re-
ceptors from their natural hosts. To address this issue
and to provide a more biologically relevant analysis of
PrV gD function, we decided to study porcine HveC.
Initially, we asked whether there were HveC homologues
in other mammalian species.
Using RT-PCR we amplified and then sequenced a
region of cDNA encoding the extracellular domain of
HveC from position 42, just downstream of the start of
the V domain, to position 336, the point at which the two
known splice isoforms diverge (Cocchi et al., 1998b;
Geraghty et al., 1998; Lopez et al., 1995). HveC se-
quences were amplified from RNA extracted from Vero
(African green monkey), BHK (hamster), MDBK (bovine),
and PK15 (porcine) cells. A single PCR product band was
obtained from all cell types without the need for nested
reactions, suggesting that, at least in these cell types,
HveC transcripts are relatively abundant.
The nucleotide sequences (including those published
for human and murine HveC) showed greater than 88%
identity for all pairwise comparisons. The deduced
amino acid sequences showed a remarkable degree of
conservation (Fig. 1, Table 1) with greater than 90% iden-
tity for all pairwise comparisons. The closest pairs were
human and monkey as well as mouse and hamster, each
with 98% identity.
Interestingly, the HveC sequence from Vero cells con-
tained a 3-amino acid insertion (Ile Thr Gln) after residue
Lys-69 of the V domain (Fig. 1). This falls within an
extended region between the predicted C and C9 beta
strands according to a published HveC structural model
(Krummenacher et al., 2000; Wimmer et al., 1994). The
insertion was not an artifact of the lengthy passage
history of Vero cells, as the HveC extracellular domain
sequence amplified from another African green monkey-
derived cell line, COS7, was identical (data not shown).
The insertion appears to have arisen from a duplication
event, as the nucleotide sequence is a direct repeat of
one a short distance upstream (encoding residues
62–64).
Having confirmed that a HveC homologue was ex-
pressed in porcine cells we determined its complete
nucleotide sequence. We used RACE to obtain the 59 and
39 ends of the porcine HveC sequence from PK15 RNA.
Both the splice isoforms of HveC (Cocchi et al., 1998b;
Geraghty et al., 1998; Lopez et al., 1995) were detected
(data not shown). We then PCR-amplified and cloned the
complete porcine HveC open reading frame.
The porcine HveC nucleotide sequence was 92% iden-
tical to that of human HveC (Geraghty et al., 1998) and
90% identical to murine HveC (Menotti et al., 2000;
Shukla et al., 2000). The 515-amino acid sequence of
porcine HveC was 96% identical to the published human
HveC sequence with 18 amino acid substitutions and
two deleted residues (Glu 443 and Gly 444 in the human
HveC sequence). The deletions occur within the cyto-
HveC s
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317PORCINE HveC MEDIATES HSV AND PrV ENTRYplasmic domain of HveC at the end of a run of seven Glu
residues. Both murine and rat HveC (Takahashi et al.,
1999) also have Glu 443 deleted. The porcine HveC
amino acid sequence is 93% identical to murine (C3H
allele) HveC, with 32 substitutions, one insertion (Pro 343
in the porcine sequence), and one deletion (Gly 447 in
the murine sequence).
Porcine HveC is a functional alphaherpesvirus
receptor
We next asked whether porcine HveC was able serve
as a receptor for a panel of four alphaherpesviruses. To
FIG. 1. Alignment of HveC extracellular domain amino acid sequenc
followed by manual adjustment. Only alterations from the human seq
underlined, and the second C domain is dash underlined. The putativ
underlined. The alignment starts at position 42 of the complete human
(GenBank Accession No. AF239762) sequences are as published (Ger
TABLE 1
Percentage Amino Acid Identities of HveC Extracellular Domains
% Human Monkey Pig Cow Mouse Hamster
Human 100 98 96 96 93 95
Monkey 100 95 95 92 93
Pig 100 97 93 94
Cow 100 93 94
Mouse 100 98
Hamster 100answer this question, we transfected CHOK1 cells with
plasmid pRM361 encoding porcine HveC, or as controls,
pBG38 (Geraghty et al., 1998) encoding human HveC, or
the vector pcDNA3, and then exposed them to lacZ
reporter viruses. CHOK1 cells do not express any of the
known alphaherpesvirus receptors and are therefore re-
sistant to HSV-1 entry (Shieh et al., 1992) and relatively
resistant to PrV entry (Nixdorf et al., 1999). Transient
expression of porcine HveC made CHOK1 cells suscep-
tible to entry of HSV-1, HSV-2, PrV, and BHV-1 (shown for
HSV-1 and PrV in Fig. 2). As expected, the human HveC-
transfected cells gave the same results, suggesting that
the two forms of HveC are functionally equivalent. The
apparent clusters of infected cells (Fig. 2, panels 1, 2, 3,
and 4) may be due to cell division after transfection, or
may stem from the gD-independent spread that can
occur to some degree with both viruses (Brunetti et al.,
1995; Peeters et al., 1992a).
To confirm these findings and to provide a more stan-
dardized method for studying porcine HveC-mediated entry
we generated a CHO K1-derived cell clone, referred to as
STAL W (Thompson et al., 1994) was used for the multiple alignment
are shown. The V domain is underlined, the first C domain is wavy
inding region of the V domain (Krummenacher et al., 2000) is double
equence. The human (GenBank Accession No. AF060231) and mouse
t al., 1998; Menotti et al., 2000).es. CLU
uence
e gD-bCHOpHveC, that stably expressed porcine HveC. Titration
of HSV-1, HSV-2, PrV, and BHV-1 lacZ reporter viruses on
3 (5 an
ualized
318 MILNE ET AL.CHOpHveC cells gave dose-dependent b-galactosidase
signals, whereas titrations on control cultures of parental
CHO K1 cells gave minimal background signals (data not
shown). Quantitative comparisons of the efficiency of entry
of different viruses were not possible in this system be-
cause of the different promoters used to drive lacZ expres-
sion. However, it was clear that porcine HveC mediates
entry of the same range of alphaherpesviruses as its hu-
man and murine homologues.
HveC-specific MAbs block porcine HveC-mediated
entry
The high sequence identity of human and porcine HveC
made it likely that human HveC-specific MAbs would rec-
ognize both forms of the protein. We used CELISA to test
cell surface expression of porcine HveC on CHOpHveC
cells and PK15 cells. Conformation-dependent (CK41) and
linear (CK6 and CK8) MAbs raised against human HveC
(Krummenacher et al., 2000) recognized porcine HveC ex-
pressed on the surface of CHOpHveC and, to a lesser
extent, on the surface of PK15 cells (Fig. 3). On the recom-
binant cells, where sufficient HveC is expressed for MAb
binding to approach saturation, the amount of CK6 and CK8
bound appeared to be twice the amount of CK41. HveC is
thought to be oligomeric (Krummenacher et al., 1999) and it
is possible that only one CK41 epitope is accessible in the
native form of the molecule.
Human HveC-mediated entry of HSV-1 (Cocchi et al.,
FIG. 2. Porcine HveC-mediated entry of alphaherpesviruses. CHO K
2); pBG38, encoding human HveC (3 and 4) or the control vector pCDNA
1, 3, and 5) or HSV-1 hrR3 (panels 2, 4, and 6). Infected cells were vis1998b; Krummenacher et al., 2000) and PrV (data not
shown) can be blocked by preexposure of cells to certainHveC V domain-specific MAbs. We showed recently that
truncated soluble forms of PrV and HSV-1 gD (termed
gDt) bind to an overlapping region of the V domain of
human HveC (Connolly et al., 2001). Having shown above
that HveC V domain-specific MAbs recognized porcine
HveC on the cell surface, it was of interest to determine
whether they could block porcine HveC-mediated entry
of HSV-1 and PrV. Titration of the conformation-depen-
dent HveC V domain-specific MAbs CK41 and R1.302
(Lopez et al., 1997) on CHOpHveC prior to exposure to
HSV-1 or PrV caused a dose-dependent inhibition of
entry (Fig. 4). We next asked whether HveC-specific
MAbs could block entry of PrV to PK15 cells. Surprisingly,
while HSV-1 entry was inhibited, PrV entry was unaf-
fected (shown for MAb R1.302 in Fig. 4C).
We conclude from these experiments that porcine HveC
retains a high level of structural and antigenic similarity with
human HveC which is reflected in the cross reactivity of
linear and conformation-dependent MAbs. Additionally, it
seems that PrV and HSV-1 use a similar site on porcine
HveC to enter CHOpHveC cells. The failure of HveC MAbs
to block entry of PrV to PK15 cells, which express functional
HveC on the surface, suggests that this virus may use
another receptor for entry to these cells.
Porcine HveCt binds PrV and HSV-1 gD
Having shown that porcine HveC was a functional
receptor for PrV as well as for other alphaherpesviruses,
were transfected with pRM361, encoding porcine HveC (panels 1 and
d 6); 48 h after transfection, cells were infected with PrV BeBlu (panels
by X-gal staining.1 cellswe next wanted to examine its interaction with gD. We
have previously used the baculovirus system to express
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319PORCINE HveC MEDIATES HSV AND PrV ENTRYtruncated soluble forms of human HveC (Krummenacher
et al., 1998, 1999) and therefore used the same system to
xpress porcine HveC. Soluble porcine HveC, truncated
t position 346 just upstream of the transmembrane
omain (termed porcine HveCt), was purified to homo-
eneity using nickel agarose. The structural integrity of
he purified protein was confirmed by recognition, in
LISA, by MAbs against linear epitopes in all three Ig
FIG. 3. Cell surface expression of HveC. Unfixed monolayers of
CHOpHveC (A), B78C10 (B), or PK15 cells (C) were stained with HveC-
specific MAbs CK6 (n ), CK8 (F), CK41 (), or as control the HveA-
specific MAb CW3 (}). Bound MAb was detected using peroxidase-
conjugated secondary antibody and absorbance was measured at 405
nm. Each point is the mean of duplicate wells.omains (not shown) and by two different conformational
Abs against the V domain (Fig. 5).
M
vOne linear V domain MAb, CK17, bound less well to
porcine HveCt than to human HveCt, with about 50-fold
more MAb needed to generate an equivalent signal in
ELISA to that obtained with human HveC (Fig. 5). The
CK17 epitope is contained within a peptide correspond-
ing to positions 80 to 94 of the human HveC sequence
(Krummenacher et al., 2000). Porcine HveC contains an
alanine in place of serine at position 84 (Fig. 1). This
FIG. 4. Blocking of porcine HveC-mediated PrV and HSV-1 entry with
anti-HveC MAbs. CHOpHveC (A and B) or PK15 cells (C) were prein-
cubated for 90 min at 4°C with increasing concentrations of HveC-
specific MAbs. Cells were then infected with 1 pfu/cell of HSV-1 KOS
hrR3 or PrV BeBlu. Entry was assessed by measurement of b-galacto-
idase activity. In (A) and (B), the signals obtained with MAbs R1.302 ( n )
nd CK41 (F) are expressed as percentages of the signal obtained with
nonblocking HveC-specific MAb, CK7. In (C), the signal obtained with
Ab R1.302 is expressed as a percentage of the signal obtained with
irus alone. Each point is the mean of duplicate wells.
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320 MILNE ET AL.change could impede CK17 binding thereby implying that
the CK17 epitope includes the N-terminal portion of this
peptide. Thus porcine HveCt is antigenically similar to its
human homologue.
We and others have previously demonstrated direct
binding of HSV-1 (Cocchi et al., 1998a; Krummenacher et
l., 1999) and PrV gDt (Connolly et al., 2001) to the V
omain of human HveC. So, having shown that porcine
veC was a bona fide receptor, we next used ELISA to
est whether HSV-1 gDt and PrV gDt were able to bind
orcine HveCt. Both forms of gDt bound to porcine HveCt
n a dose-dependent manner (Fig. 6). The binding curves
or each form of gDt obtained with human HveCt and
orcine HveCt could be superimposed, suggesting that
he two truncated receptors were functionally similar and
hat, at least with regard to gD binding, porcine HveCt
etained a conformation similar to that of human HveCt.
veC-specific MAbs block binding of PrV and HSV-1
D to porcine HveCt
FIG. 5. Recognition of porcine HveCt by HveC-specific MAbs. ELISA
plates were coated with human (A) or porcine (B) HveCt. HveC-specific
MAbs CK17 ( n ), CK41 (F), and R1.302 (), or the control MAb CW3 (}),
were titrated onto the plate. Bound MAb was then detected. Each point
is the mean of duplicate wells.We showed above that certain HveC-specific MAbs
ere able to block porcine HveC-mediated entry ofSV-1 and PrV. It was likely that this was due to a direct
ffect of the MAbs on gD binding. We therefore used
LISA to test these MAbs for the ability to block binding
f gDt to HveCt.
Titration of HveC-specific MAbs CK41 and R1.302
aused a dose-dependent decrease in the binding of PrV
nd HSV-1 gD to human and porcine HveCt (Fig. 7).
1.302 was consistently more effective at blocking than
K41 and appeared to have an identical effect regard-
ess of receptor or gD. CK41 blocked HSV-1 gD some-
hat more effectively than PrV gD. Thus, MAbs CK41 and
1.302 have similar but distinct properties. Both block
inding of gDt to immobilized porcine HveCt and this is
robably the mechanism by which they inhibit virus entry.
orcine HveC binds HSV-1 and PrV gD with different
ffinities
Our previous studies of the interaction of human HveC
ith HSV-1 and PrV gDt showed that the affinity of the
nteraction is approximately 10-fold higher with PrV gD
han with HSV-1 gD (Connolly et al., 2001). It was possi-
FIG. 6. PrV and HSV-1gD bind to human and porcine HveC. HSV-1 (A)
or PrV (B) gDt were titrated on ELISA plates coated with human ( n ) or
porcine (F) HveCt. Bound gD was detected with R7 antiserum (against
HSV gD) or MAbs 6D8MB4 and S4B1-1611 (against PrV gD). Each point
is the mean of duplicate wells.
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321PORCINE HveC MEDIATES HSV AND PrV ENTRYble that the higher affinity of PrV gD for human HveCt
might reflect an abnormal interaction with a receptor
from a species that is not a normal host for PrV. If so, the
affinity for porcine HveC might be expected to be equiv-
alent to that of HSV-1 gD for human HveC. Alternatively,
if the higher affinity were a genuine feature of the PrV
gD–HveC interaction it would, presumably, be the same
for porcine HveC.
To distinguish between these two possibilities, we
used competition ELISA to compare binding of the two
forms of gDt and to test whether they could compete for
binding to porcine HveCt. We showed previously that PrV
and HSV-1 gDt compete for binding to human HveCt
(Connolly et al., 2001). In the next experiments, porcine
HveCt was immobilized on the ELISA plate and increas-
ing concentrations of one form of gDt were used to
compete the binding of a constant concentration of the
other form of gDt.
PrV gDt effectively competed binding of HSV-1 gDt to
FIG. 7. HveC MAbs block binding of PrV (B and D) and HSV-1gDt (A
n ), were incubated for 2 h on ELISA plates coated with porcine (A a
ncubated for 1 h. Bound gD was then detected; 100% binding corresp
uplicate wells.porcine HveCt, with 50% inhibition of HSV-1 gDt binding
at a concentration of approximately 0.2 mM (Fig. 8). Bycontrast, HSV-1 gDt competed PrV gDt binding much
less effectively, with only about 60% inhibition of PrV gDt
binding at the highest concentration of HSV-1 gDt tested
(10 mM). The disparity between the ability of the two
orms of gDt to compete binding was consistent with the
igher affinity of PrV gDt for human HveC and suggested
hat this was also true for porcine HveC. Furthermore, the
ompetition curves shown in Fig. 8 could be superim-
osed on similar curves generated with human HveCt
data not shown); thus it appeared that the species origin
f the receptor did not affect gD binding.
To confirm and quantitate the affinity difference be-
ween HSV-1 and PrV gDt we used optical biosensor
nalysis. We have previously used this technique to
tudy the interaction of various forms of gDt with recep-
ors (Krummenacher et al., 1999; Rux et al., 1998; Whit-
beck et al., 1999; Willis et al., 1998b). We therefore used
this approach to compare the interaction of PrV and
HSV-1 gDt with the porcine HveCt.
to HveC. HveC MAbs CK41 (F) or R1.302 (), or the control MAb CW3
r human (C and D) HveCt; 0.5 mM PrV or HSV-1gDt was added and
the signal obtained with no antibody present. Points are the mean ofand C)
nd B) oDifferent concentrations of PrV gDt or HSV-1 gDt were
flowed over porcine HveCt immobilized on a biosensor
d
s
i
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322 MILNE ET AL.chip and binding and dissociation were monitored in real
time (Fig. 9). Binding data were analyzed using a 1:1
interaction model to generate estimates of the associa-
tion and dissociation rates and the affinity (Table 2). PrV
gDt bound with an affinity (K D) of 1.9 3 10
27 M, whereas
the affinity of HSV-1 gDT was significantly lower at 1.9 3
1026 M. This result was consistent with the ELISA results
escribed above. The 10-fold higher affinity of PrV gDt
temmed almost entirely from a higher on-rate (k on); that
s, PrV gDt bound to immobilized HveCt more rapidly
han did HSV-1 gDt (on-rate of 7.6 3 104 s21 M21 for PrV
gDt compared to 4.4 3 103 s21 M21 for HSV-1 gDt).
Comparison of the binding kinetics of the two forms of
gD for porcine HveC with the published data for their
interaction with human HveC (Krummenacher et al.,
1999; Connolly et al., 2001) shows that, for both forms of
gDt, the affinities for human and porcine HveC are es-
sentially identical.
DISCUSSION
Alphaherpesviruses are a diverse group with repre-
sentatives that infect a huge variety of mammalian spe-
cies. There is ample evidence that HSV-1 and PrV, the
most widely studied members of the group, and probably
all of the mammalian alphaherpesviruses, share a com-
mon entry pathway. At the most general level, they en-
code the same set of entry glycoproteins (Mettenleiter,
1994; Spear, 1993) and deletions of these glycoproteins
FIG. 8. Competition between PrV and HSV-1gDt for porcine HveCt
binding. ELISA plates were coated with porcine HveCt. Serial dilutions
of HSV-1gDt (F) or PrV gDt (n ) were then used to compete the binding
of a constant amount (0.5 mM) of the other form of gDt (test gDt). The
amount of bound test gDt obtained with each concentration of com-
petitor gDt was expressed as a percentage of amount bound in the
presence of the equivalent amount of BSA. Each point is the mean of
duplicate wells. Detection was with rabbit polyclonal anti-PrV or anti-
HSV gDt.have effects on PrV similar to those on HSV (Forrester et
al., 1992; Klupp et al., 1997; Ligas and Johnson, 1988;Peeters et al., 1992b; Rauh and Mettenleiter, 1991; Roop
et al., 1993). Additionally, PrV and HSV-1 can compete for
binding to Vero cells and expression of gD from either
virus can block infection with both viruses (Campadelli-
Fiume et al., 1988; Geraghty et al., 2000; Johnson and
Spear, 1989; Lee and Fuller, 1993). The latter observa-
tions can be explained by the demonstrated ability of PrV
and HSV-1 to use a common receptor, HveC.
The rationale for the work described in this article was
that if PrV can use human HveC as a receptor then it was
FIG. 9. Real time analysis of PrV and HSV-1gDt binding to porcine
HveCt. The indicated concentrations of PrV gDt (A) or HSV-1gDt (B)
were flowed for 2 min (association) across porcine HveCt immobilized
on a CM5 BIACORE chip in a BIAcore X instrument. Buffer alone was
then flowed for 2 min to allow dissociation. Data were collected at 5 Hz.
The sensorgrams represent raw data with signals from a blank control
flow cell and from injections of buffer alone subtracted. For clarity one
of every 25 collected data points is plotted. The solid lines represent
the best fit of the complete data set using global fitting.
TABLE 2
Kinetic and Affinity Values for PrV gDt and HSV gDt–Porcine HveCt
Complex Formationa
kon (10
3 M21 s21)
(on rate)
koff (10
23 s21)
(off rate)
KD (10
26 M)b
(affinity)
HSV gDt 4.4 8.2 1.9
PrV gDt 76.4 14.5 0.19a Data are from a representative experiment.
b KD 5 koff/kon.
323PORCINE HveC MEDIATES HSV AND PrV ENTRYlikely to be able to use a porcine HveC homologue.
Because of the considerable sequence differences be-
tween HSV and PrV gD, studies of their interactions with
HveC homologues from their natural hosts would be of
use in dissecting gD function. We initially set out to
determine whether pigs and other mammalian species
encoded HveC homologues.
The conservation of HveC amino acid sequences was
striking, with greater than 90% identity over the extracel-
lular domain in all pairwise comparisons. The related
proteins HveB and nectin 3 are also highly conserved
between species with 72% (HveB) and 92% (nectin 3)
amino acid identities between the human and the murine
homologues (Satoh-Horikawa et al., 2000; Shukla et al.,
1999b; Warner et al., 1998). One explanation for the high
sequence conservation of this distinct group of immuno-
globulin superfamily proteins is the homophilic interac-
tion that they can undergo (Lopez et al., 1998; Satoh-
Horikawa et al., 2000; Takahashi et al., 1999). Given that
each is effectively its own ligand, a single mutation can
be thought of as simultaneously altering both receptor
and ligand with a correspondingly enhanced effect, per-
haps creating a strong pressure for conservation. Al-
though HveC is remarkably conserved, alignment of all of
the known HveC extracellular domain sequences shows
that a total of 30 residues are varied in at least one
sequence. Variant residues appeared to be distributed
evenly over the protein with 13 in the V domain (which is
larger than the two C domains), 5 in the first C domain
and 4 in the second C domain, and 8 in spacer regions
between domains.
As well as point mutations, we found a 3-amino acid
insertion in the HveC V domain sequence from Vero
cells. Entry of HSV-1 and PrV into Vero cells can be
partially blocked by HveC MAbs (data not shown), indi-
cating that Vero HveC is able to mediate virus entry. It
should be noted that the insertion in Vero HveC is out-
side of the predicted gD-binding region of HveC (Fig. 1;
Krummenacher et al., 2000). The observation that entry of
both viruses into Vero cells can be blocked by HveC
MAbs provides a likely explanation for the published
observation that PrV and HSV-1 can compete for a re-
ceptor on Vero cells (Lee and Fuller, 1993). Our data
would suggest that this receptor was HveC, which is
consistent with this being the only known receptor that is
used by both viruses (Geraghty et al., 1998).
Having shown that porcine HveC was highly similar to
human HveC, we then wanted to study its ability to
function as a virus receptor. Despite their high sequence
identity, it was possible that porcine and human HveC
might differ in their receptor activity. In fact, we found that
porcine and human HveC were functionally indistin-
guishable.
We showed previously that the binding affinity of PrV
gDt for human HveCt was 10-fold higher than that of
HSV-1gDt (Connolly et al., 2001). Here, we found that thesame was true with porcine HveCt. It is curious that
although PrV and HSV-1gDt both bind HveCt, possibly at
the same site, they do so with differing affinities. This
may reflect a fundamental difference between the two
viruses in the ways in which HveC functions as a recep-
tor. However, given the similar entry pathways of the two
viruses, this seems unlikely. An alternative explanation is
that the higher affinity is due to structural differences, for
example, the lack of N-glycosylation on PrV gDt. High
affinity binding may contribute to the ability of PrV to use
a broad range of receptors (Geraghty et al., 1998; Warner
et al., 1998). In this regard, it would be interesting to
determine the affinities of PrV gDt for its other receptors,
HveB and HveD.
We could not block PrV entry to PK15 cells with HveC
MAbs. By contrast, HSV-1 entry could be partially
blocked, confirming our CELISA data that HveC on PK15
cells is accessible and showing that, at least for HSV, it
is functional. The higher affinity of PrV gD for HveC is
unlikely to be the explanation for the failure of blocking,
as we showed that HveC-mediated entry of PrV to
CHOpHveC cells can be blocked by these MAbs. In a
study of PrV entry to murine cell lines, Shukla et al. found
that anti-murine HveB MAbs almost completely blocked
PrV entry into B78H1 cells yet had no effect on entry into
NIH3T3 cells, although both these cell types express
murine HveB mRNA (Shukla et al., 1999b). It was sug-
gested that PrV was able to use another receptor to enter
NIH3T3 cells. For blocking with MAbs to be detectable,
the target receptor must account for a substantial pro-
portion of total virus entry. PrV can use three known
receptors (Geraghty et al., 1998; Shukla et al., 1999b;
Warner et al., 1998) and the existence of cells that are
resistant to HSV but susceptible to PrV (Cocchi et al.,
1998b; Perez and Fuller, 1998) indicates that there is at
least one unknown PrV receptor. The lack of blocking on
PK15 cells may reflect the preferential use of one or more
of the latter. Perhaps for a similar reason, the efficiency
with which HSV-1 entry can be blocked varies widely
according to cell type (Krummenacher et al., 2000). We
have not investigated the expression of any other recep-
tors on PK15 cells.
It remains the case that, while our data show clearly
that PrV can use porcine HveC as a receptor, we have no
evidence that this receptor is actually used in vivo. In-
deed, such formal proof does not yet exist for any of the
recently identified alphaherpesvirus receptors. It seems
very unlikely, however, that gD, which shows consider-
able sequence variation within the alphaherpesviruses,
would retain the ability to bind to multiple receptors,
particularly to the most widely used, HveC, if these were
not used in vivo.
The functional equivalence of human and porcine
HveC is not surprising in view of their high sequence
identity. HveC mediates entry of a broader range of
viruses than any of the other known receptors and HSV-1
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324 MILNE ET AL.and PrV have now been shown to use HveC from four
species (human, mouse, pig, and monkey). It may well be
that most, if not all, alphaherpesviruses are able to use
HveC. Coupled with its striking conservation, this sug-
gests that HveC, unlike the other known alphaherpesvi-
rus receptors, has some of the attributes of a pan-alpha-
herpesvirus receptor. The widespread use of HveC is
remarkable given the extent of sequence divergence
between the viral gD homologues. An obvious implica-
tion is that the HveC-binding domain of gD has remained
highly stable through evolution and/or that it is essential
for gD function. It has been suggested that the US seg-
ment of alphaherpesviral genomes, in which gD is en-
coded, might contain sequences that were acquired from
the host (McGeoch, 1989). Given that HveC interacts with
itself, it is tempting to speculate that gD, or at least the
HveC-binding domain of gD, might be derived from a
segment of the host HveC gene and hence able to mimic
this interaction by virtue of a similar structure. Regard-
less of the origin of gD, the existence of divergent viral
ligands able to bind to a highly conserved receptor
provides an interesting model system for refining our
understanding of receptor structure and function.
MATERIALS AND METHODS
RNA isolation, polymerase chain reaction, and DNA
sequencing
RNA was extracted from 2 3 106 cells using TRIzol (BRL)
ccording to the manufacturers instructions. Contaminating
NA was removed by DNase digestion. Complementary
NA was synthesized from 2 mg total RNA using Moloney
murine leukemia virus reverse transcriptase (BRL). HveC
extracellular domain sequences were amplified by poly-
merase chain reaction (PCR) using Expand High Fidelity
polymerase mix (Boehringer Mannhein) with the upstream
primer hPRR1 59, GCGTGATCAGGTGGTCCAGGTGAAC-
GACTCCATGTAT, and downstream primer hPRR1 39H-,
CGGTGATCAATGTTCGGGAGGAGACGGGGTGTA (Krum-
menacher et al., 1998). Fifty-microliter amplification reac-
tions contained 1.75 units enzyme activity, 0.4 mM each
dNTP, 0.15 mM each primer, and 1.5 mM MgCl2 in the
anufacturer’s reaction buffer. PCR was carried out on a
erkin–Elmer GeneAmp PCR system 9700 thermal cycler
ith an initial denaturation at 94°C for 30 s, then 40 cycles
f: 94°C, 30 s; 60°C, 30 s; 72°C, 2 min. Product bands
predicted size: 976 base pairs) were purified from agarose
sing Geneclean spin columns (BIO101) and sequenced at
he University of Pennsylvania Department of Genetics
NA sequencing facility using an ABI 377 automated se-
uencer. PCR products generated from two separate RNA
amples were used to assemble each sequence.
Sequences of the 59 and 39 ends of the porcine HveC
equence were obtained using 59 and 39 rapid amplificationof cDNA ends (RACE), both according to supplied protocols
(BRL). For 59 RACE, first-strand cDNA synthesis was primedith hPRR139H-. HveC C2ND3, CGGCCCGGGCTAATGAT-
ATGATGATGATGCTGCACGTTGAGAGTGAGGCTTTCC,
as used as gene specific primer (GSP) and HveC C1ST3,
GGCCCGGGCTAATGATGATGATGATGATGCATCACCGT-
AGATTGAGCTGGCTTTCT, as nested GSP. For 39 RACE,
PRR159 was used as GSP then primers HveCGSP2,
CAGCTCAATCTCACGGTGATG, and HveCGSP3, CTAT-
TCGACCAGCATCCTGCTGGTGCT, were used as nested
SPs. Products were either cloned or sequenced directly.
The complete porcine HveC nucleotide sequence was
mplified using Pfu polymerase (Stratagene). Conditions
were as above except that the manufacturer’s buffer was
used and annealing was at 51°C for 1 min. Primers were
pHveC 5.1, GGACCCGTCGACCCCGATGGCT and pHveC
3.2, CTGAGCGTCGACGCGGTTACACGTACCACTCCT-
TCTTGGA, each containing a SalI site (underlined) for clon-
ing. The band-purified product was cloned into XhoI-
digested pCDNA3.1 as a SalI fragment. Clones from three
independent PCR amplifications were used to confirm the
sequence. One clone, pRM361, was used in all subsequent
experiments.
All HveC sequence numbering in this article corre-
sponds to human HveC and starts at the first methionine.
The nucleotide sequences described in this article have
been deposited in the GenBank data base with the fol-
lowing accession numbers: AF308632 (porcine HveC),
AF308635 (Vero HveC extracellular domain), AF308634
(BHK HveC extracellular domain), and AF308633 (MDBK
HveC extracellular domain).
Cells and viruses
Vero and PK15 cells were maintained in Dulbecco’s
minimal essential medium (DMEM) supplemented with
5% fetal calf serum, 100 U/ml penicillin, and 100 mg/ml
treptomycin. CHO K1 and B78C10 were maintained in
am’s F12 medium supplemented with 10% FCS and
ntibiotics. This medium was further supplemented with
00 mg/ml G418 for maintenance of CHOpHveC and 250
mg/ml G418 and 150 mg/ml puromycin for B78C10, which
are murine B78 H1 cells stably expressing human HveC
(C.G. Miller et al., submitted).
Suspension cultures of Spodoptera frugiperda Sf9
cells were maintained in Sf900II medium (BRL). For
monolayer cultures Grace’s medium (BRL) supplemented
with 10% FCS and antibiotics was used.
b-galactosidase-expressing reporter viruses were
used throughout this project. HSV-1 hrR3 was provided
by S. Weller (University of Connecticut) and contains the
Escherichia coli lacZ gene at the ICP6 (UL39) locus
under the control of the ICP6 promoter (Goldstein and
Weller, 1988). PrV BeBlu was provided by L.Enquist
(Princeton University) and contains the lacZ gene at the
glycoprotein G locus under the control of the gG pro-
moter (Banfield et al., 1998). HSV-1 hrR3 was grown and
titrated in Vero cells, PrV BeBlu in PK15 cells.
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325PORCINE HveC MEDIATES HSV AND PrV ENTRYAntibodies and purified proteins
The HveC-specific MAbs CK6, CK7, CK8, CK17, and
CK41 were raised against baculovirus-expressed human
HveC(346t) and have been described (Krummenacher et
al., 2000). The anti-HveC MAb R1.302 (Lopez et al., 1997)
as obtained from S. McClellan (Beckman Coulter). MAb
W3 recognizes HveA (Whitbeck et al., 2001) and was
sed as a negative control. IgG were purified from ascitic
luids using protein G Sepharose. Rabbit polyclonal se-
um R7 was raised against HSV2 gD purified from trans-
ected cells (Isola et al., 1989). Rabbit polyclonal anti PrV
gD serum was obtained from M.W. Wathen. Anti-PrV gD
MAb S4B1.1611 was provided by N.Coe (Coe and Men-
geling, 1990) and MAb 6D8 MB4 was obtained from the
ATCC.
Production and purification of baculovirus-expressed
HSV-1 gD(306t), termed HSV-1gDt in this article, PrV gDt
and human HveC(346t), termed human HveCt in this
article, have been described (Krummenacher et al., 1998;
Sisk et al., 1994; Connolly et al., 2001).
Protein expression and purification
The porcine HveC extracellular domain sequence was
amplified by PCR using Pfu polymerase with primers
hPRR159 and hPRR139, CGGTGATCAATGATGATGATGAT-
GATGTTCGGGAGGAGACGGGGTGTA (Krummenacher et
al., 1998). The product was cloned into pVTBAC produc-
ing pRM362 which was used to generate recombinant
baculovirus using established methods (Willis et al.,
1998a). The resulting soluble truncated form of porcine
HveC, termed Porcine HveCt, contained residues 31 to
345 of the protein with an extra aspartic acid residue at
the N-terminus introduced from the vector and a six-
histidine tag introduced by primer hPRR139 at the C-
terminus. Porcine HveCt was purified on a nickel–aga-
rose column and then concentrated using an Ultrafree
centrifugal filter device with a 10K cutoff (Millipore). The
purified protein appeared as a single band on silver-
stained gel and was reactive with HveC MAbs by West-
ern blot and ELISA.
Enzyme-linked immunosorbent assay (ELISA)
For the gD binding ELISA, porcine or human HveCt (10
mg/ml in PBS) was coated onto microtiter plates for 2 h at
room temperature (RT). Plates were washed with 0.1%
Tween 20 in PBS (PBS–Tween), blocked by incubation (1
h RT) with PBS containing 5% powdered milk and 0.2%
Tween 20 (blocking solution), washed again, and then
incubated overnight with various concentrations of gDt in
blocking solution. Bound HSV-1gDt was detected using
R7 antiserum (1/1000 in blocking solution) and bound PrV
gDt using polyclonal anti-PrV gD serum (1/500 in block-
ing solution) or a cocktail of MAbs 6D8MB4 and S4B1-
1611 (1/500 and 1/750 dilutions of ascitic fluid in blockingsolution). Horseradish peroxidase-conjugated goat anti-
mouse Ig or anti-rabbit Ig was used to detect bound
antibodies as described (Krummenacher et al., 1998). For
MAb binding ELISA, plates were coated with receptor at
4°C overnight, washed, blocked as above, and then
incubated (2 h RT) with various concentrations of MAb in
blocking solution. For blocking ELISA, plates were
coated with HveC as in the gD binding ELISA, incubated
(2 h RT) with MAbs, washed, and incubated (1 h RT) with
gDt (0.5 mM) in blocking solution. Bound gDt was de-
tected as above. For competition ELISA, one form of gD
(competing gD) was used to block binding of the other
form (test gD) to immobilized HveC. Plates were coated
with HveC as in the gD binding ELISA and then incu-
bated (4°C overnight) with various concentrations of
competing gDt, or BSA as control, and 0.5 mM test gDt.
ound test gD was detected as above.
ELISA
To detect HveC on the cell surface, we used a modi-
ication of a published CELISA method (Geraghty et al.,
000). Monolayers in 96-well plates (4 3 104 cells/well)
were incubated (2 h at 4°C) with MAbs diluted in PBS
containing 3% bovine serum albumin, 0.9 mM CaCl2, and
500 mM MgCl2 (PBS–BSA). After three PBS washes, cells
ere fixed (30 min RT) with 3% paraformaldehyde (in
BS) and washed as before. Bound MAb was then de-
ected (1 h RT) with horseradish peroxidase-conjugated
oat anti-mouse IgG (1/1000 in PBS–BSA). Cells were
ashed three times with PBS containing 0.1% Tween 20,
nd then processed as for a standard ELISA.
ptical biosensor analysis
Real-time analysis of gDt binding to porcine HveCt
as carried out using a BIACORE X optical biosensor
BIAcore AB) at 25°C essentially as described previously
Krummenacher et al., 1999; Rux et al., 1998; Whitbeck et
l., 1999; Willis et al., 1998b; Connolly et al., 2001). The
unning buffer was HBS-EP (BIAcore) containing 0.005%
ween 20. Approximately 1750 resonance units (RU) of
orcine HveCt were coupled to flow cell 2 (Fc2) of a CM5
ensor chip via primary amines. Flow cell 1 (Fc1) was
ctivated and blocked without the addition of protein. For
nalysis of gDt binding to HveCt the flow path included
oth flow cells, the flow rate was 50 ml/min, and the data
collection rate was 5 Hz. Serial dilutions (in HBS-EP) of
PrV and HSV-1gDt were allowed to bind for 2 min and the
wash was delayed 2 min to allow for a smooth dissoci-
ation curve. The chip surface was regenerated with short
pulses of Na2CO3 (pH 9.5–10.5) until the response signal
on both flow cells returned to baseline. Sensorgrams
were corrected for nonspecific binding by subtracting the
signal achieved on Fc1 signal from that of Fc2 signal. The
signal obtained when buffer alone was injected was then
subtracted from the total signal. Sensorgrams were an-
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culations assumed that both forms of gDt were dimeric.
Model curve fitting was performed using global fitting
with a 1:1 Langmuir binding model with drifting baseline.
This is the simplest model for the interaction between a
receptor and a ligand. It follows the equation A 1 B 5
AB. The rate of association (k on) is measured from the
orward reaction and the rate of dissociation (k off) mea-
sured from the reverse reaction. k off/k on 5 K D. We dis-
counted the effects of mass transport by running sam-
ples at different flow rates and ensuring that signals
were not flow-rate-dependent.
Transient expression and entry assay
Subconfluent CHO K1 cells in 24-well plates were
transfected with 1 mg/well plasmid DNA using Fugene
(Boehringer Mannheim). Forty-eight hours after transfec-
tion, cells were infected with lacZ reporter viruses at
input multiplicities of 1 pfu/cell. After 21 h, cells were
fixed with methanol/acetone (1:1) and then stained for
b-galactosidase expression using X-gal (MacGregor et
al., 1991).
Generation of cell lines
CHO K1 cells were transfected with pRM361. Forty-
eight hours post-transfection, cells were refed with me-
dium containing 500 mg/ml G418. Surviving cells were
then cloned twice by limiting dilution. Clones were
screened for HveC expression by CELISA using antibody
CK6 and for virus entry using HSV-1 hrR3 and PrV BeBlu.
A representative clone, termed CHOpHveC, was chosen
for further analysis.
Virus blocking assay
Cells were seeded overnight at 4 3 104/well into
96-well plates. Various concentrations of MAbs (in the
appropriate growth medium) were added (50 ml/well) to
chilled monolayers and held at 4°C for 90 min. HSV-1
hrR3 or PrV BeBlu (at input multiplicities of 1–2 pfu/cell;
50-ml volume) was added and the plates incubated for 5
CHO K1) or 7 (PK15) h at 37°C in a humid atmosphere
ith 5% CO2. Cells were then washed once with growth
edium, to remove any inoculum-derived b-galactosi-
dase, and lysed by the addition of 100 ml of the same
medium containing 1% NP-40. Fifty microliters of cell
lysate was mixed with an equal volume of chlorophenol
red-b-D-galactopyranoside, a chromogenic substrate for
b-galactosidase. Enzyme activity was monitored by mea-
suring the absorbance at 595 nm over 50 min and was
expressed as the change in optical density over time
(DOD/h). This figure was used as an estimate of the
extent of virus entry.ACKNOWLEDGMENTS
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